PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Hospital Infection Control Committee, Hospital Santa Paula, Ímpar Serviços Hospitalares S.A., São Paulo, São Paulo, Brazil. Electronic address: cristhieni@uol.com.br.\', \'Institute for Education and Research, Hospital Santa Paula, Ímpar Serviços Hospitalares S.A., São Paulo, São Paulo, Brazil. Electronic address: rodrigo.santos@santapaula.com.br.\', \'Research and Development Department, Diagnósticos da América S.A. (Dasa), Brazil.\', \'Clinical Research Department, Diagnósticos da América S.A. (Dasa), Brazil.\', \'Institute for Education and Research, Hospital Santa Paula, Ímpar Serviços Hospitalares S.A., São Paulo, São Paulo, Brazil.\', \'Strategy Board, Diagnósticos da América S.A. (Dasa), Brazil.\', \'Heart Institute (InCor), Medical School, Universidade de São Paulo, São Paulo, São Paulo, Brazil.\', \'Infectious Diseases Division, Hospital das Clínicas, Universidade de São Paulo, São Paulo, São Paulo, Brazil; Infectious Diseases Department, Diagnósticos da América S.A. (Dasa), Brazil.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0924-8579(21)00206-510.1016/j.ijantimicag.2021.106428
?:hasPublicationType
?:journal
  • International journal of antimicrobial agents
is ?:pmid of
?:pmid
?:pmid
  • 34454044
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.699
?:rankingScore_hIndex
  • 107
is ?:relation_isRelatedTo_publication of
?:title
  • Hydroxychloroquine plus azithromycin early treatment of mild COVID-19 in an outpatient setting: a randomized, double-blinded, placebo-controlled clinical trial evaluating viral clearance.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all